Skip to main content
. 2022 Jan 28;109(3):274–282. doi: 10.1093/bjs/znab443

Table 1.

Clinicopathological variables in patients with unifocal, unilateral breast lesions

Magnetic seed (n = 946) Wire (n = 1170) P
Age (years)* 59.9(10.4) 60.4(10.6) 0.210
BMI (kg/m2 ) 27.9 (24.4–32.1) 28 (24–32) 0.555
Unknown 93 235
Lesion size (mm) n = 764 n = 931
 Mammogram 13 (9–20) 13 (9–20) 0.598
 Unknown 105 75
 Ultrasound 12 (9–18) 12 (8–17) 0.219
 Unknown 182 239
Tumour stage n = 891 n = 1147
 Tis 167 (18.7) 256 (22.3) 0.189
 T1 541 (60.7) 637 (55.5)
 T2 126 (14.1) 172 (15)
 T3 12 (1.3) 16 (1.4)
 yT0 45 (5.1) 66 (5.8)
 Unknown 55 23
Nodal stage n = 881 n = 1147
 N0 747 (84.8) 973 (85.4) 0.543
 N1 92 (10.4) 105 (9.2)
 N2 7 (0.8) 11 (1)
 N3 2 (0.2) 8 (0.7)
 yN0 33 (3.7) 42 (3.7)
 Unknown 65 31
Histological diagnosis n = 945 n = 1169
 Invasive ductal and lobular 592 (62.6) 715 (61.2) 0.051
 DCIS 172 (18.2) 264 (22.6)
 Mixed invasive/DCIS 120 (12.7) 127 (10.9)
 Other 61 (6.5) 63 (5.4)
 Unknown 1 1
Neoadjuvant therapy n = 946 n = 1170
 Chemotherapy 100 (10.6) 117 (10) 0.679
 Endocrine therapy 34 (3.6) 50 (4.3)
 None 812 (85.8) 1003 (85.7)
Surgery n = 943 n = 1170
 Lumpectomy for single lesion 759 (80.5) 1009 (86.2) 0.002
 Mammoplasty involving skin/volume reduction 164 (17.4) 142 (12.1)
 Lumpectomy for multiple lesions 4 (0.4) 8 (0.7)
 Other 16 (1.7) 11 (0.9)
 Unknown 3 -
Concurrent axillary surgery n = 935 n = 1168
 No 225 (24.1) 328 (28.1) 0.095
 Sentinel node biopsy 658 (70.4) 784 (67.1)
 Axillary clearance 52 (5.6) 56 (4.8)
 Unknown 11 2

Values in parentheses are percentages unless indicated otherwise; *values are mean(s.d.), values are median (i.q.r.). DCIS, ductal carcinoma in situ. t–test was used for Age, Mann–Whitney U test was used for BMI, mammogram, ultrasound, and Chi squared was used for all the others namely Tis, N0, Invasive ductal and lobular, chemotherapy, lumpectomy for single lesion, concurrent axillary surgery (No).